Term ended Jul 7, 2023 · High confidence
20-year base term ended Jul 7, 2023
Held by Collegium Pharmaceutical, Inc.
Filed Jul 17, 2012 as application 13/551,455 · Granted Jun 2, 2015
Base term, 20 years from filing
Today
Term ended Jul 7, 2023
2003
2026
Clock starts
Jul 7, 2003
Jul 7, 2003
Term ended
Jul 7, 2023
Jul 7, 2023
Granted
Jun 2, 2015
Jun 2, 2015
base term
after the term ends
fee events
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 7,399,488, US 7,771,707, US 8,449,909, US 8,557,291, to Jul 7, 2023. The term already ends on or before that date, so the cap shortened nothing.
2 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
36
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jul 7, 2003, when application 10/614,866, the earliest non-provisional in its chain, was filed (this one was filed Jul 17, 2012) | Jul 7, 2023 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 7,399,488, US 7,771,707, US 8,449,909, US 8,557,291) | resolves to Jul 7, 2023, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 2 maintenance fees paid | term ended | High confidence |
| Computed term end | The steps above, in order | Jul 7, 2023 | High confidence |
Partial family
| US 7,399,488 | Term ended Mar 2025 | Mar 2025 |
| US 7,771,707 | In force Oct 2028 | Oct 2028 |
| Application 12/112,937 | Abandoned not computed | not computed |
| Application 12/112,993 | Abandoned not computed | not computed |
| US 8,557,291 | Term ended Mar 2025 | Mar 2025 |
| US 8,449,909 | Term ended Mar 2025 | Mar 2025 |
| US 8,840,928 | Term ended Jul 2023 | Jul 2023 |
| US 9,044,398 | this patent Jul 2023 | Jul 2023 |
8 of 36 applications in this family shown, earliest filings first. Partial: 5 of the 36 have no file history here, so a row comes from the patent's own record or names the application alone. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Apr 3, 2013 Reel 30145, frame 160 | Hirsh, Jane; Klibanov, Alexander M.; Swager, Timothy M.; Buchwald, Stephen L.; Lo, Whe Yong; Fleming, Alison B.; Rariy, Roman V. | Collegium Pharmaceutical, Inc. | Assignment of Assignor's Interest |
| Feb 13, 2020 Reel 51817, frame 583 | Collegium Pharmaceutical, Inc. | Biopharma Credit PLC | Security Interest |
| Mar 22, 2022 Reel 59474, frame 526 | Collegium Pharmaceutical, Inc. | Biopharma Credit PLC | Amended and Restated Patent Security Agreement |
| Dec 23, 2025 Reel 73308, frame 342 | Biopharma Credit PLC | Collegium Pharmaceutical, Inc. | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 7,399,488, US 7,771,707, US 8,449,909, US 8,557,291, ends no earlier than this term, so it caps nothing.
Citations
44
later US patents cite this one
That is top 10% of utility patents granted in 2015 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.